Recombinant Human H295N Protein，His

H295N cells, derived from human adrenal cortex, have emerged as a pivotal model for studying steroidogenesis and adrenal function, particularly in the context of adrenal hyperplasia and tumorigenesis. Research into the H295N recombinant protein focuses on its role in the synthesis of various steroid hormones such as cortisol, aldosterone, and androgens, which are critical for numerous physiological processes. These cells maintain a steroidogenic phenotype, retaining the expression of key enzymes involved in the biosynthesis of adrenal steroids, making them a valuable tool for investigating the mechanisms underlying adrenal disorders. Moreover, the study of H295N cells has implications in understanding the pathophysiology of conditions like Cushing's syndrome and congenital adrenal hyperplasia, offering insights into potential therapeutic targets. The recombinant proteins produced by H295N cells can also facilitate the development of biochemical assays and drug screening processes, ultimately contributing to advancements in endocrine research and therapeutics. As researchers delve deeper into the molecular pathways regulated by these proteins, they aim to uncover new strategies for diagnosing and treating adrenal-related diseases, enhancing the precision of therapeutic interventions in clinical settings. The ongoing exploration of H295N recombinant proteins represents a significant step forward in endocrinology, bridging the gap between basic science and clinical application.